Drug trial

Woman battling cervical cancer is injected with experimental tumor-destroying vaccine

A 35-year-old woman battling stage four cervical cancer has become one of the world’s first patients to be injected with an experimental vaccine that doctors hope could become the future of cancer treatment. Kelly Potter was diagnosed with an aggressive form of cervical cancer in July of last year. Her initial treatments did little to stop the cancer from metastasizing, and it spread to her liver and lungs. Potter was one of 30 patients selected for the trial, which is testing the effects of a new vaccine designed to destroy solid tumors. Scientists hope it could prove to be the answer for patients for whom traditional treatments, like chemotherapy, did not work. The trial is expected to run for the next two years.

Potter said just being a part of it has buoyed her spirits. “To be part of this trial has changed my life for the better. It’s been a very positive experience and really interesting. I feel honored to be involved,” Potter said. “It’s fantastic to be part of something that could be groundbreaking.” The experimental nature of the treatment, however, is not lost on Potter and she’s sober about the possibility of a recovery. “My hope for the future is to beat the cancer for as long as I can, and if I can’t, I have come to terms with that. I would like to go on and inspire others with cancer,” she said.

Read the full story at The Independent.

Leave a Reply

Your email address will not be published. Required fields are marked *